| Literature DB >> 25243169 |
Abstract
The development of a convenient mathematical application for testing the antioxidant potential of standard and novel therapeutic agents is essential for the research community to perform evaluations in a more precise form. The in vitro oxidative hemolysis inhibition assay, despite its relevance for in vivo responses, lacks a proper mathematical model to quantify the responses. In this work, a simple nonlinear time-dose tool to test the effectiveness of antioxidant compounds is presented. The model was verified with available experimental data from the bibliography. The model helps to describe accurately the antioxidant response as a function of time and dose allowing comparisons between compounds. Its advantages are a simple application, provision of parametric estimates that characterize the response, simplification of the protocol, economization of experimental effort, and facilitation of rigorous comparisons among the effects of different compounds and experimental approaches. Finally, other effectors that may obstruct or be of interest for the antioxidant determination are also modeled in similar principles. Thus, the basis of more complex multivariable models is provided. In all experimental data fitted, the calculated parameters were always statistically significant, the equations prove to be consistent, and the correlation coefficient of determination was in all cases higher than 0.98.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25243169 PMCID: PMC4160643 DOI: 10.1155/2014/632971
Source DB: PubMed Journal: Biomed Res Int Impact factor: 3.411
Description of the references used to collect data to be analyzed in this study, the figures, variable or agent involved, and some relevant conditions of the assays.
| Case | Reference | Figure | Effector | Conditions | Method |
|---|---|---|---|---|---|
| A: Antioxidant effector analysis | |||||
| A1 | [ | Figure 20 | Trolox (0-(25)-125 | 0.7% (v/v) in PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAa |
| A2 | [ | Figure 3 | Trolox (0-(25)-100 | 0.7% (v/v) in PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAb |
| A3 | [ | Figure 5 | Ascorbic Acid (0-(100)-300 | 0.7% (v/v) in PBS (pH 7.4), 37°C, 50 mM AAPH. | OxHLIAa |
| A4 | [ | Figure 1(a) | CazNH (0, 6.17, 9.26, 12.3, 15.4, 20.6 | 10 mM PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAa |
| A5 | [ | Figure 1(b) | IsbNH (0, 8.26, 12.4, 16.5, 20.7, 24.8 | 10 mM PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAa |
| A6 | [ | Figure 1(c) | DpaNH (0, 3, 6, 9, 12, 15 | 10 mM PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAa |
| A7 | [ | Figure 1(d) | PtzNH (0, 20.3, 30.5, 37.3, 50.8, 61.0 | 10 mM PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAa |
| A8 | [ | Figure 1(e) | PozNH (0, 9.27, 10.8, 12.4, 13.9, 15.5 | 10 mM PBS (pH 7.4), 37°C, 40 mM AAPH. | OxHLIAa |
|
| |||||
| B: Another effector analysis | |||||
| E1 | [ | Figure 3 | AAPH (0-(20)-100 | 0.7% (v/v) in PBS (pH 7.4), 37°C. | OxHLIAa |
| E2 | [ | Figure 1 | DTAB surfactant (2.25, 4.5, 5.625, 6.75, 11.25%). | 10 mM PBS (pH 7.4), 37°C. | Osmotic fragility testa |
| E3 | [ | Figure 7 | NaHCO3 (1, 1.5, 1.8, 2 mM). | pH 7.2, 20°C. | Isotonic hemolytic testa |
| E4 | [ | Figure 4 | Temperature (15, 20, 25, 30, 35, 40, 45°C). | 10 mM PBS (pH 7.4), palytoxin (0.25 pg/ | Palytoxin hemolytic activityc |
aTest-tube format.
bMicroplate format.
cHalf-way between test-tube and microplate format.
Short review of different mathematical methodologies from related fields of study, such as the hemolytic bioassays, antioxidant, and dose-response theory.
| Reference | Type∗ | Use∗∗ | Description |
|---|---|---|---|
| From related hemolytic analytical techniques | |||
| [ | M | OMT | Sophisticated mechanistic model to evaluate the erythrocyte lysis analyzed with a scanning flow cytometer in isotonic solution, obtaining several parameters (volume, surface area, hemoglobin concentration, elasticity. and critical tension of membrane, etc.) that allow us to evaluate the lysis. |
| [ | E | OMT | A mathematical model based on the Gaussian distribution function to measure the degree of osmotic fragility to test the degree of resistance of red blood cells to hemolysis was developed. It provides parameters that define the midpoint, the dispersion, and maximum hemolysis, respectively. |
| [ | E | OMT | Demonstrating the suitability of the Weibull survival distribution to study the surfactant-induced erythrocyte hemolysis (osmotic fragility test) connecting its parameters to blood properties. |
| [ | E | PHA | Developing a toxicological dynamic model, applying in equivalent form the Weibull and Logistic equation, to describe the hemolysis of erythrocytes by palytoxin and its inhibition by ouabain, allowing us to detect this potentially nonprotein marine toxin. |
|
| |||
| From the antioxidant field | |||
| [ | E | DAA | A bivariate model was proposed. It allows us to obtain the simultaneous solution of a series of oxidation kinetics of a dose-response of antioxidants. Its application is simple, provides parametric estimates which characterize oxidative process, and facilitates rigorous comparisons. |
| [ | E | DAA | A kinetic approach to evaluate the efficiency of antioxidants in scavenging the radical generated in the |
| [ | E | DAA | A general mathematical model for lipid oxidation in food systems based on the logistic equation. A simple method was described for the evaluation of the model parameters. Variations of these numerical values were also associated with varying pretreatment and storage conditions. |
|
| |||
| From the dose-response theory | |||
| [ | E | DDRA | A general bivariate method to describe the time-dose-response curves for physiological and pharmacological studies. The method permits rigorous statistical analysis, provides a basis for pooling of information from separate experiments, and determines characteristics shared by curves. |
| [ | E | DDRA | A review to describe the importance of the time dimension on dose-responses for toxic chemicals. In many situations, the effect of a toxic chemical on a biological system depends on both the intensity and the duration of exposure. |
| [ | E | DDRA | The suitability of several common descriptive models for the study of dose-response relationships is discussed, and changes are introduced that improve their suitability, generalize their application, and lead to their possible application for multivariable analysis. |
| [ | E | DDRA | A review of various properties of the Hill equation which is widely used in many pharmacokinetic-pharmacodynamic models to describe nonlinear drug dose-response relationships. The main mechanistic aspect and multivariate potential applications are also discussed. |
*Model type: mechanistic (M); empirical (E).
**Use: Osmotic fragility test (OFT); palytoxin hemolytic activity (PHA); different antioxidant assays (DAA); different dose-response approaches (DDRA).
Part A shows the additional parameters of interest (v , v , and λ) and reparameterization equations deduced from algebraic modifications of (5) to make such values explicit and therefore to compute their confidence intervals. Part B shows four of the most common effector perturbations (linear, hyperbolic, sigmoidal, and bell modifications) on the kinetic description of the survival erythrocyte population.
| A: Additional parameters of interest | ||
|---|---|---|
| Parameter calculation | Reparameterization form of ( | Eq. number |
|
|
| (i) |
|
|
| (ii) |
|
|
| (iii) |
|
| ||
| B: effector variations on the survival population | ||
| Effector relation | Model chosen to modify parameters of ( | Eq. no. |
|
| ||
| Linear ( |
| (iv) |
| Hyperbolic ( |
| (v) |
| Sigmoidal ( |
| (vi) |
| Bell ( |
| (vii) |
Part A: maximum rate of hemolysis (v ); the rate at the value (v ); the lag-phase (λ); and G = (α − 1)/α.
Part B: l 1 is the slope (t/e units); l 2 is the intercept (t units); h 1 is the asymptotic value of the hyperbolic relation (parameter modified units); h 2 is 1/e units;s 1 is the asymptotic value (parameter modified units) of the nonlinear relation, s 2 is the IC50 value (e units); s 3 is a shape parameter related to the maximum slope of the response; b 1 is the maximum value (parameter modified units), b 2 is related to the distance between the tails of the function (e units), b 3 is a value related to the asymmetry of the bell profile, and b 4 is the effector value at which b 1 takes place (e units).
Figure 1Kinetics of the haemolytic oxidation at different antioxidant concentrations and relationships among the concentration of antioxidant and the parameters that characterize its activity. (a) The kinetic series of the survival erythrocyte population fitted (lines) to the kinetic model (5) using the antioxidant trolox at various concentrations 0-(25)-125 μM (dots). The results were obtained from the study of Takebayashi et al. [26] (Case A1 in Table 1) who recently made a detailed revision of the method. Parametric estimations are showed in Table 4. (b), (c), and (d) show the pattern of the parametric responses as a function of the antioxidant concentration. The parameters τ and λ show a linear behavior, while the rate is the modified final v and v displaying a decreasing asymptotic hyperbolic relation.
Parametric estimations and statistic information of the kinetic series of the survival erythrocyte population inhibited by the antioxidant trolox and fitted to the kinetic model (5).
| Effector | Kinetic parameters | Statistics | Reparameterization | ||||
|---|---|---|---|---|---|---|---|
| Trolox ( |
|
|
|
|
|
|
|
| 0 | 100 ± 1.15 | 68.12 ± 10.03 | 4.59 ± 2.48 | 0.9992 | 2.34 ± 1.01 | 2.35 ± 0.88 | 39.92 ± 12.12 |
| 25 | 100 ± 1.15 | 86.05 ± 10.63 | 6.44 ± 5.17 | 0.9993 | 2.59 ± 0.98 | 2.63 ± 0.47 | 59.87 ± 17.22 |
| 50 | 100 ± 1.15 | 102.96 ± 10.74 | 8.26 ± 7.73 | 0.9984 | 2.78 ± 0.75 | 2.85 ± 0.65 | 78.16 ± 21.34 |
| 75 | 100 ± 1.15 | 117.26 ± 10.53 | 10.14 ± 6.89 | 0.9988 | 3.00 ± 0.68 | 3.09 ± 0.32 | 94.04 ± 18.75 |
| 100 | 100 ± 1.15 | 130.76 ± 10.47 | 11.20 ± 6.92 | 0.9987 | 2.97 ± 0.59 | 3.06 ± 0.89 | 107.22 ± 21.24 |
| 125 | 100 ± 1.15 | 144.26 ±10.60 | 10.86 ± 8.30 | 0.9971 | 2.61 ± 0.85 | 2.69 ± 0.97 | 117.51 ± 31.25 |
Figure 2Trolox antioxidant case (Case A1, Table 1), presented in Figure 1 and analyzed simultaneously in terms of time and the dose by model (7). Statistical results in part A of Table 5 (Case A1).
Numeric results corresponding to the time-dose antioxidant responses collected from the bibliography (enumerated in Table 1) adjusted to (7) perturbed by (iv) in Table 3.
| Parametric estimates | Statistics | ||||||
|---|---|---|---|---|---|---|---|
| Effector | Kinetic parameters | Effector modifying coefficients |
| ||||
|
|
|
|
|
| |||
| A1 | Trolox | 100.0 ± 0.5 | 70.5 ± 0.9 | 4.83 ± 6.9 | 0.0086 ± 2.2 | 0.0121 ± 16.5 | 0.9973 |
| A2 | Trolox | 100.0 ± 0.3 | 84.2 ± 0.4 | 5.50 ± 3.6 | 0.0063 ± 1.4 | 0.0115 ± 9.7 | 0.9993 |
| A3 | Ascorbic Acid | 100.0 ± 1.1 | 139.8 ± 1.8 | 4.97 ± 12.4 | 0.0032 ± 4.6 | 0.0030 ± 37.2 | 0.9937 |
| A4 | CazNH | 100.0 ± 1.1 | 199.7 ± 1.3 | 5.03 ± 12.2 | 0.0470 ± 0.3 | −0.0092 ± 11.9 | 0.9877 |
| A5 | IsbNH | 100.0 ± 1.0 | 208.1 ± 1.4 | 5.07 ± 7.5 | 0.0356 ± 3.9 | −0.0073 ± 46.8 | 0.9884 |
| A6 | DpaNH | 100.0 ± 1.7 | 222.6 ± 1.8 | 6.48 ± 11.5 | 0.0798 ± 4.4 | −0.0169 ± 47.8 | 0.9713 |
| A7 | PtzNH | 100.0 ± 0.8 | 209.0 ± 1.2 | 6.65 ± 7.9 | 0.0184 ± 2.9 | −0.0031 ± 47.4 | 0.9892 |
| A8 | PozNH | 100.0 ± 0.9 | 186.5 ± 1.3 | 9.09 ± 11.3 | 0.1014 ± 2.6 | −0.0295 ± 20.6 | 0.9890 |
Confidence intervals for α = 0.05. R adj 2: adjusted determination coefficient.
Figure 3Graphical representation of the time-dose antioxidant responses collected from the bibliography (enumerated in Table 1) adjusted to (7) perturbed by (iv) (Table 3).
Figure 4Graphical results of applying the kinetic model (5) or any other reparameterization form to the survival erythrocyte population curve affected by different effectors varying one or more parameters with one or various of the phenomenological functions described—equations ((iv), (v), (vi), and (vii); Table 3).